NCF2 can serve as a biomarker related to ferroptosis in various diseases, such as Alzheimer’s disease [29], amyotrophic lateral sclerosis [30], sepsis-induced acute lung injury [31], and LN [11]. Here, NCF2 is linked to early-onset autosomal dominant Alzheimer disease.